FDA Approves New Option for Soft-Tissue Sarcoma
(MedPage Today) -- Trabectedin slowed disease progression versus dacarbazine
Source: MedPage Today Public Health - Category: American Health Source Type: news
More News: American Health | Health | International Medicine & Public Health | Sarcomas | Soft Tissue Sarcoma